Seres Therapeutics (MCRB) Shares Hit on SER-109 Phase 2 ECOSPOR Data
Tweet Send to a Friend
Seres Therapeutics (NASDAQ: MCRB) shares are down around 77 percent today after ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
